Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 236 participants.
Also called NCT04532333
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 236 participants
- Sponsor
- Registry
-
NCT04532333
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04532333. Randomized; no masking; primary purpose prevention. Start 2020-08 (anticipated); primary completion 2021-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms
- Acronym
- BUILD
- Condition
- Subarachnoid Hemorrhage, Aneurysmal
- Intervention (Drug)
- Bivalirudin 250 MG Injection
- Intervention (Drug)
- Heparin
- Lead sponsor
- Changhai Hospital
- Collaborator
- The First Affiliated Hospital of Zhengzhou University
- Collaborator
- Zhejiang University
- Collaborator
- Wuhan University
- Collaborator
- Qilu Hospital of Shandong University
- Collaborator
- The First People's Hospital of Changzhou
Record details
- Record id
cardio:ct-nct04532333- Content hash
52aacb6b16b595deb8316ce42650b49f0743e8bf194ded2622d1b696de969c32